Wild-type p53 regulates human ribonucleotide reductase by protein-protein interaction with p53R2 as well as hRRM2 subunits

Cancer Research

Volumn 63, Issue 5, 2003, Pages 980-986

  Xue, Lijun ^a,b   Zhou, Bingsen ^a   Liu, Xiyong ^a   Qiu, Weihua ^a   Jin, Zhongchu ^b   Yen, Yun ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEOTIDE; PROTEIN P53; PROTEIN SUBUNIT; RIBONUCLEOTIDE; RIBONUCLEOTIDE REDUCTASE;

ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DNA REPAIR; DNA SYNTHESIS; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME REGULATION; GENE TARGETING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; ULTRAVIOLET IRRADIATION; ULTRAVIOLET RADIATION;

CELL CYCLE PROTEINS; CELL NUCLEUS; CYTOPLASM; HUMANS; KB CELLS; KINETICS; MUTATION; PROTEIN BINDING; RIBONUCLEOSIDE DIPHOSPHATE REDUCTASE; RIBONUCLEOTIDE REDUCTASES; RNA-BINDING PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; ULTRAVIOLET RAYS;

EID: 0037374051     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Wright, J. A., Chan, A. K., Choy, B. K., Hurta, R. A., and McClarty, G. A. Regulation and drug resistance mechanisms of mammalian ribonucleotide reductase, and the significance to DNA synthesis. Biochem. Cell Biol., 68: 1364-1371, 1990.
2. Hurta, R. A., and Wright, J. A. Alterations in the activity and regulation of mammalian ribonucleotide reductase by chlorambucil, a DNA damaging agent. J. Biol. Chem., 267: 7066-7071, 1992.
3. Jordan, A., and Reichard. P. Ribonucleotide reductases. Annu. Rev. Biochem., 67: 71-98, 1998.
4. Tanaka, H., Arakawa, H., Yamaguchi, T., Shiraishi, K., Fukuda, S., Matsui, K., Takei, Y., and Nakamura. Y. A. Ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature (Lond.), 404: 42-49, 2000.
5. Guittet, O., Hakansson, P., Voevodskaya, N., Fridd, S., Graslund, A., Arakawa, H., Nakamura, Y., and Thelander, L. Mammalian p53R2 protein forms an active ribonucleotide reductase in vitro with the R1 protein, which is expressed both in resting cells in response to DNA damage and in proliferating cells. J. Biol. Chem., 276: 40647-40651, 2001.
6. Oren. M., and Rotter, V. Introduction: p53 - the first twenty years. Cell Mol. Life Sci., 55: 9-11, 1999.
7. May, P., and May, E. Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene, 18: 7621-7636, 1999.
8. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell, 88: 323-331, 1997.
9. Bates, S., and Vousden, K. H. p53 in signaling checkpoint arrest or apoptosis. Curr. Opin. Genet. Dev., 6: 12-18, 1996.
10. El-Deiry, W. S. Regulation of p53 downstream genes. Semin. Cancer Biol., 8: 345-357, 1998.
11. Okorokov, A. L., Rubbi, C. P., Metcalfe, S., and Milner, J. The interaction of p53 with the neuclear matrix is mediated by F-actin and modulated by DNA damage. Oncogene, 21: 356-367. 2002.
12. Achanta, G., Pelicano, H., Feng, L., Plunkett, W., and Huang, P. Interaction of p53 and DNA-PK in response to nucleoside analogues: potential role as a sensor complex for DNA damage. Cancer Res., 61: 8723-8729, 2001.
13. Chabes, A., and Thelander, L. Controlled protein degradation regulates ribonucleotide reductase activity in proliferating mammalian cells during the normal cell cycle and in response to DNA damage and replication blocks. J. Biol. Chem., 275: 17747-17753, 2000.
14. Gottifredi, V., Shieh, S., Taya, Y., and Prives, C. p53 accumulates but is functionally impaired when DNA synthesis is blocked. Proc. Natl. Acad. Sci. USA, 98: 1036-1041, 2001.
15. Reddy, G. P., and Fager, R. S. Replitase: a complex integrating dNTP synthesis and DNA replication. Crit. Rev. Eukaryot. Gene Expr., 3: 255-277, 1993.
16. Mathews, C. K., and Slabaugh, M. B. Eukaryotic DNA metabolism. Are deoxyribonucleotides channeled to replication sites? Exp. Cell Res., 162: 285-295, 1986.
17. Chiba, P., Bacon, P. E., and Cory, J. G. Studies directed toward testing the "channeling" hypothesis-ribonucleotides - DNA in leukemia L1210 cells. Biochem. Biophys. Res. Commun., 123: 656-662, 1984.
18. Prem veer Reddy, G., and Pardee, A. B. Multienzyme complex for metabolic channeling in mammalian DNA replication. Proc. Natl. Acad. Sci. USA, 77: 3312-3316, 1980.
19. Engstrom, Y., Rozell, B., Hansson, H. A., Stemme, S., and Thelander, L. Localization of ribonucleotide reductase in mammalian cells. EMBO. J., 3: 863-867, 1984.
20. Engstrom, Y., and Rozell, B. Immunocytochemical evidence for the cytoplasmic localization and differential expression during the cell cycle of the M1 and M2 subunits of mammalian ribonucleotide reductase. EMBO. J., 7: 1615-1620, 1988.
21. Yamaguchi, T., Matsuda, K., Sagiya, Y., Iwadate, M., Fujino, M. A., Nakamura, Y., and Arakawa, H. p53R2-dependent pathway for DNA synthesis in a p53-regulated cell cycle checkpoint. Cancer Res., 61: 8256-8262, 2001.
22. Isaacs, W. B., Carter, B. S., and Ewing, C. M. Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. Cancer Res., 51: 4716-4720, 1991.
23. Chang, N. S. A potential role of p53 and WOX1 in mitochondrial apoptosis. Int. J. Mol. Med., 9: 19-24, 2002.
24. Zhou, B., Mo, X., Xue, L. L., Liu, X., Qiu, W., and Yen, Y. Human ribonucleotide reductase subunit, hRRM2 complement p53R2 in response to UV induced repair in p53 mutant cells. Proc. Am. Assoc. Cancer Res., 43: 1151, 2002.
25. Goan, Y. G., Zhou, B. S., Hu, E., Mi, S., and Yen, Y. Overstatement of ribonucleotide reductase as a mechanism of resistance to 2.2-difluorodeoxycitidine in the human KB cancer cell line. Cancer Res., 59: 4204-4207, 1999.
26. Cory, J. G., and Sato, A. Regulation of ribonucleotide reductase activity in mammalian cells. Mol. Cell. Biochem., 53: 257-266, 1983.
27. Ali, M. A., McWeeney, D., Milosavljevic, A., Jurka, J., and Jariwalla, R. J. Enhanced malignant transformation induced by expression of a distinct protein domain of ribonucleotide reductase large subunit from herpes simplex virus type 2. Proc. Natl. Acad. Sci. USA, 88: 8257-8261, 1991.
28. Zhou, B. S., Ker, R., and Yen, Y. Ribonucleotide reductase overexpression affects metastatic potential in human KB cancer cells. Clin. Exp. Metastasis, 16: 43-49, 1998.
29. Ashcroft, M., and Vousden, K. H. Regulation of p53 stability. Oncogene, 18: 7637-7643, 1999.
30. Ford, J. M., and Hanawalt, P. C. Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in UV-irradiated human fibroblasts. J. Biol. Chem., 272: 28073-28080, 1997.
31. Smith, M. L., and Fomace, A. J., Jr. p53-mediated protective responses to UV irradiation. Proc. Natl. Acad. Sci. USA, 94: 12255-12257, 1997.
32. Friedberg, E. C., Walker, G. C., and Siede, W. (eds). DNA repair and mutagenesis. Washington, D.C.: American Society for Microbiology Press, 1995.
33. Smith, M. L., and Seo, Y. R. p53 regulation of DNA excision repair pathways. Mutagenesis, 17: 149-156, 2002.
34. Zhan, Q., Carrier, F., and Fomace, A. J., Jr. Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol. Cell. Biol., 13: 4242-4250, 1993.
35. Qiu, W., Zhou, B., Darwish, D., Liu, X., Xue, L., and Yen, Y. Characterization of enzymatic properties of the human ribonucleotide reductase holoenzyme reconstituted in vitro from hRRM1, hRRM2, and p53R2 subunits. Proc. Am. Assoc. Cancer Res., 43: 1142, 2002.
36. Smith, M. L., Chen, I. T., Zhan, Q., O'Connor, P. M., and Fornace, A. J., Jr. Involvement of the p53 tumour suppressor in repair of UV-type DNA damage. Oncogene, 10: 1053-1059, 1995.
37. Eriksson, S., Graslund, A., Skog, S., Thelander, L., and Tribukait, B. Cell cycle-dependent regulation of mammalian ribonucleotide reductase. The S phase-correlated increase in subunit M2 is regulated by de novo protein synthesis. J. Biol. Chem., 259: 11695-11700, 1984.
38. Albert, D. A., Nodzenski, E., Yim, G., and Kowalski, J. Effect of cyclic AMP on the cell cycle regulation of ribonucleotide reductase M2 subunit messenger RNA concentrations in wild-type and mutant S49 T lymphoma cells. J. Cell. Physiol., 143, 251-256, 1990.
39. Nakano, K., Bálint, E., Ashcroft, M., and Vousden, K. H. A ribonucleotide reductase gene is a transcriptional target of p53 and p73. Oncogene, 19: 4283-4289, 2000.
40. Elledge, S. J., and Davis, R. W. DNA damage induction of ribonucleotide reductase. Mol. Cell. Biol., 9: 4932-4940, 1989.
41. Kuo, M. L., and Kinsella, T. J. Expression of ribonucleotide reductase after ionizing radiation in human cervical carcinoma cells. Cancer Res., 58: 2245-2252, 1998.
42. Engstrom, Y., Eriksson, S., Jildevik, I., Skog, S., Thelander, L., and Tribukait, B. Cell cycle-dependent expression of mammalian ribonucleotide reductase. Differential regulation of the two subunits. J. Biol. Chem., 260: 9114-9116, 1985.
43. Mann, G. J., Musgrove, E. A., Fox, R. M., and Thelander, L. Ribonucleotide reductase M1 subunit in cellular proliferation, quiescence, and differentiation. Cancer Res., 48: 5151-5156, 1988.
44. Björklund, S., Hjortsberg, K., Johansson, E., and Thelander, L. Structure and promoter characterization of the gene encoding the large subunit (R1 protein) of mouse ribonucleotide reductase. Proc. Natl. Acad. Sci. USA, 90: 11322-11326, 1993.
45. Sun, L., and Fuchs, J. A. Escherichia coli ribonucleotide reductase expression is cell cycle regulated. Mol. Biol. Cell, 3: 1094-1105, 1992.
46. Skoog, L., and Bjursell, G. Nuclear and cytoplasmic pools of deoxyribonucleoside triphosphates in Chinese hamster ovary cells. J. Biol. Chem., 249: 6434-6438, 1974.
47. Lozano, G., and Elledge, S. J. p53 sends nucleotides to repair DNA. Nature (Lond.), 404: 24-25, 2000.